These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 18585119

  • 1. Incidence and risk factors for low trauma fractures in men with prostate cancer.
    Ahlborg HG, Nguyen ND, Center JR, Eisman JA, Nguyen TV.
    Bone; 2008 Sep; 43(3):556-60. PubMed ID: 18585119
    [Abstract] [Full Text] [Related]

  • 2. Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy.
    Conde FA, Sarna L, Oka RK, Vredevoe DL, Rettig MB, Aronson WJ.
    Urology; 2004 Aug; 64(2):335-40. PubMed ID: 15302490
    [Abstract] [Full Text] [Related]

  • 3. Alendronate decreases the fracture risk in patients with prostate cancer on androgen-deprivation therapy and with severe osteopenia or osteoporosis.
    Planas J, Trilla E, Raventós C, Cecchini L, Orsola A, Salvador C, Placer J, Encabo G, Morote J.
    BJU Int; 2009 Dec; 104(11):1637-40. PubMed ID: 19549260
    [Abstract] [Full Text] [Related]

  • 4. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.
    Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR.
    Cancer; 2004 Mar 01; 100(5):892-9. PubMed ID: 14983482
    [Abstract] [Full Text] [Related]

  • 5. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
    Kaptoge S, Benevolenskaya LI, Bhalla AK, Cannata JB, Boonen S, Falch JA, Felsenberg D, Finn JD, Nuti R, Hoszowski K, Lorenc R, Miazgowski T, Jajic I, Lyritis G, Masaryk P, Naves-Diaz M, Poor G, Reid DM, Scheidt-Nave C, Stepan JJ, Todd CJ, Weber K, Woolf AD, Roy DK, Lunt M, Pye SR, O'neill TW, Silman AJ, Reeve J.
    Bone; 2005 Mar 01; 36(3):387-98. PubMed ID: 15777673
    [Abstract] [Full Text] [Related]

  • 6. Fracture risk in androgen deprivation therapy: a Canadian population based analysis.
    Lau YK, Lee E, Prior HJ, Lix LM, Metge CJ, Leslie WD.
    Can J Urol; 2009 Dec 01; 16(6):4908-14. PubMed ID: 20003666
    [Abstract] [Full Text] [Related]

  • 7. Natural history of bone complications in men with prostate carcinoma initiating androgen deprivation therapy.
    Krupski TL, Smith MR, Lee WC, Pashos CL, Brandman J, Wang Q, Botteman M, Litwin MS.
    Cancer; 2004 Aug 01; 101(3):541-9. PubMed ID: 15274067
    [Abstract] [Full Text] [Related]

  • 8. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.
    Smith MR, Lee WC, Brandman J, Wang Q, Botteman M, Pashos CL.
    J Clin Oncol; 2005 Nov 01; 23(31):7897-903. PubMed ID: 16258089
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fracture risk in Danish men with prostate cancer: a nationwide register study.
    Abrahamsen B, Nielsen MF, Eskildsen P, Andersen JT, Walter S, Brixen K.
    BJU Int; 2007 Oct 01; 100(4):749-54. PubMed ID: 17822455
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Osteoporosis and fractures after androgen deprivation initiation for prostate cancer.
    Malcolm JB, Derweesh IH, Kincade MC, DiBlasio CJ, Lamar KD, Wake RW, Patterson AL.
    Can J Urol; 2007 Jun 01; 14(3):3551-9. PubMed ID: 17594745
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low calcaneal bone mineral density and the risk of distal forearm fracture in women and men: a population-based case-control study.
    Atroshi I, Ahlander F, Billsten M, Ahlborg HG, Mellström D, Ohlsson C, Ljunggren O, Karlsson MK.
    Bone; 2009 Oct 01; 45(4):789-93. PubMed ID: 19539795
    [Abstract] [Full Text] [Related]

  • 19. Low width of tubular bones is associated with increased risk of fragility fracture in elderly men--the MINOS study.
    Szulc P, Munoz F, Duboeuf F, Marchand F, Delmas PD.
    Bone; 2006 Apr 01; 38(4):595-602. PubMed ID: 16249130
    [Abstract] [Full Text] [Related]

  • 20. Lifestyle factors and duration of androgen deprivation affect bone mineral density of patients with prostate cancer during first year of therapy.
    Ryan CW, Huo D, Stallings JW, Davis RL, Beer TM, McWhorter LT.
    Urology; 2007 Jul 01; 70(1):122-6. PubMed ID: 17656221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.